1887

Abstract

The presence of both K and O antigens of was found necessary to protect the organism from either complement-mediated serum killing or phagocytosis in the absence of specific antisera. Optimal phagocytic ingestion of NCTC 5055 could be achieved in the presence of either anti-K or anti-O sera or to a much smaller extent in antisera raised against a rough unencapsulated mutant (M10B) derived from NCTC 5055. Anti-O sera failed to opsonize a clinical klebsiella isolate (DL1) possessing immunologically identical lipopolysac-charide, but did so when the amount of capsule was physically reduced. The serum sensitivity of the encapsulated strains was unaffected by the addition of specific antisera. Fresh serum was bacteriostatic for an unencapsulated smooth mutant (M10) derived from NCTC 5055. This bacteriostatic effect was reduced by heat-inactivation of the serum or by the addition of anti-O serum. M10 was rendered sensitive to the bactericidal action of serum in the presence of antisera raised against M10B or after chelation with MgEGTA to isolate alternative complement pathway activity. The rough unencapsulated mutant (M10B) was rapidly killed by fresh serum, an effect which could be delayed by chelation with MgEGTA. The serum sensitivity of M10B was unaffected by the presence of anti-M10B sera. Thus, the O antigen, unlike the K antigen, of these klebsiella strains is not antiphagocytic but it does confer some protection against the rapid bactericidal activity of serum complement.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-129-7-2181
1983-07-01
2021-08-04
Loading full text...

Full text loading...

/deliver/fulltext/micro/129/7/mic-129-7-2181.html?itemId=/content/journal/micro/10.1099/00221287-129-7-2181&mimeType=html&fmt=ahah

References

  1. Braude A.I., Douglas H., Davis C.E. 1973; Treatment and prevention of intravascular coagulation with antiserum to endotoxin. Journal of Infectious Diseases 128:S157–164
    [Google Scholar]
  2. Brown M.R.W. 1977; Nutrient depletion and antibiotic susceptibility. Journal of Antimicrobial Chemotherapy 3:198–200
    [Google Scholar]
  3. Chedid L., Parant M., Parant F., Bozer F. 1968; A proposed mechanism for natural immunity to enterobacterial pathogens. Journal of Immunology 100:292–306
    [Google Scholar]
  4. Crowley J.P., Zinner S.H., Peter G. 1982; Opsonisation of serum sensitive and serum resistant E. coli by rough mutant (Re) antisera. Journal of Laboratory and Clinical Medicine 90:197–205
    [Google Scholar]
  5. Ehrenworth L., Baer H. 1956; The pathogenicity of K. pneumoniae for mice - the relationship to the quantity and rate of production of type- specific capsular polysaccharide. Journal of Bacteriology 72:713–717
    [Google Scholar]
  6. Finch J.E., Brown M.R.W. 1978; The effect of growth environment on the killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leucocytes and by cationic proteins. Infection and Immunity 20:340–346
    [Google Scholar]
  7. Fine D.P., Marney S.R., Colley D.G., Sergent J.S., Des-Prez R.M. 1972; C3 shunt activation in human serum chelated with EGTA. Journal of Immunology 109:807–809
    [Google Scholar]
  8. Guttman R.M., Waibron B.A. 1975; Bactericidal blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection. Clinical and Experimental Immunology 19:121–130
    [Google Scholar]
  9. Howard C.J., Glyn A.A. 1971; The virulence for mice of strains of E. coli related to the effect of their K antigens on their resistance to phagocytosis and killing by complement. Immunology 20:767–777
    [Google Scholar]
  10. Ihara I., Harada Y., Ihara S., Kawakami M. 1982; A new complement-dependent bactericidal factor found in non-immune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella. Journal of Immunology 128:1256–1260
    [Google Scholar]
  11. Jones R.J., Roe E.A., Gupta J.L. 1979; Controlled trials of a polyvalent Pseudomonas vaccine in burns. Lancet ii:977–983
    [Google Scholar]
  12. Mccabe W.R. 1972; Immunisation with R mutants of S. minnesota. I. Protection against challenge with heterologous Gram-negative bacilli. Journal of Immunology 108:601–610
    [Google Scholar]
  13. Miles A.A., Misra S.S. 1938; The estimation of the bactericidal power of blood. Journal of Hygiene 38:732–748
    [Google Scholar]
  14. Montgomerie J.Z., Ota J.K. 1980; Klebsiella bacteraemia. Archives of Internal Medicine 140:525–527
    [Google Scholar]
  15. Nimmich W. 1970; Die chemische Zusammensetzung der Klebsiella-LPS (O Antigene). Pathologica et microbiologica 36:179–190
    [Google Scholar]
  16. Powell D.A. 1979; Structure, solution properties and biological interactions of some microbial extracellular polysaccharides. In Microbial Polysaccharides and Polysaccharases pp. 117–160 Berkeley R.C.W., Gooday G.W., Ellwood D.C. Edited by London: Academic Press for the Society for General Microbiology;
    [Google Scholar]
  17. Poxton I.R., Sutherland I.W. 1976; Isolation of rough mutants of Klebsiella aerogenes and their synthesis of polysaccharides. Journal of General Microbiology 96:195–202
    [Google Scholar]
  18. Rennie R.P., Duncan B.R. 1974; Combined biochemical and serological typing of clinical isolates of Klebsiella. Applied Microbiology 28:534–539
    [Google Scholar]
  19. Robbins J.B., Schneerson R., Egan W.B., Vann W., Liu D.T. 1980; Virulence properties of bacterial capsular polysaccharides - unanswered questions. In The Molecular Basis of Microbial Pathogenicity the report of the Dahlem Workshop on The Molecular Basis of the Infective Process pp. 115–132 Smith H., Skehel J.J., Turner M.J. Edited by Weinheim: Verlag Chemie;
    [Google Scholar]
  20. Root R.K., Ellman K., Frank M.M. 1972; Bacterial and opsonic properties of C4 deficient guinea pig serum. Journal of Immunology 93:477–486
    [Google Scholar]
  21. Rowley D. 1968; Sensitivity of rough and smooth Gram-negative bacteria to the bactericidal action of serum. Journal of Bacteriology 95:1647–1650
    [Google Scholar]
  22. Stendahl O., Norman B., Edebo L. 1979; Influence of O and K antigens on the surface properties of E. coli in relation to phagocytosis. Acta pathologica et microbiologica scandinavica B87:85–91
    [Google Scholar]
  23. Stendahl O., Edebo L. 1972; Phagocytosis of mutants of Salmonella typhimurium by rabbit PMNs. Acta pathologica et microbiologica scandinavica B80:481–488
    [Google Scholar]
  24. Taylor P.W. 1972; An antibacterial blocking factor in the serum of two patients with upper respiratory tract infections. Clinical Science 43:23–27
    [Google Scholar]
  25. Taylor P.W., Messner P., Parton R. 1981; Effect of growth environment on cell envelope components of E. coli in relation to human serum sensitivity. Journal of Medical Microbiology 14:9–20
    [Google Scholar]
  26. Traub W.H. 1981; Failure of a commercial, intravenously applicable IgG(ab2) preparation (Gamma-venin) to enhance human serum bactericidal activity against Serratia marcescens. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene(Abteilung I Originale A) 249:504–511
    [Google Scholar]
  27. Van Dijk C., Verbrugh H.A., Van Erne-Van Dertol M.E., Peters R., Verhoef J. 1981; Escherichia coli antibodies in opsonisation and protection against infection. Journal of Medical Microbiology 14:381–389
    [Google Scholar]
  28. Westphal O., Jann K. 1965; Bacterial lipopoly-saccharides: extraction with phenol/water and further applications of the procedure. Methods in Carbohydrate Chemistry 583–91 Whistler R.L. Edited by New York: Academic Press;
    [Google Scholar]
  29. Young L.S., Stevens P., Ingram J. 1975; Functional role of antibody against core glycolipid of Enterobacteriaceae. Journal of Clinical Investigation 56:850–861
    [Google Scholar]
  30. Young S.E.J. 1982; Bacteraemia 1975–1980: a survey of cases reported to the PHLS Communicable Disease Surveillance Centre. Journal of Infection 5:19–26
    [Google Scholar]
  31. Ziegler E.J., Mccutchan J.A., Braude A.I. 1978; Clinical trials of core glycolipid in Gramnegative bacteraemia. Transactions of the Association of American Physicians 91:253–258
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-129-7-2181
Loading
/content/journal/micro/10.1099/00221287-129-7-2181
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error